Is microdosing a GLP-1 safe? Questions to ask a clinician

A lower dose does not lower the bar for screening. What safety actually depends on with a microdose program, and the questions worth asking before you start.

Asking whether microdosing a GLP-1 is safe is really asking two questions: is a low dose of this medication risky, and is the service prescribing it doing the things that make any prescription safe. The second question matters more, and it is the one with clearer answers.

Does a lower dose make a GLP-1 safer?

Partly, and not in the way people hope. Fewer dose increases means fewer of the gastrointestinal side effects that cluster around them. But the serious items on the approved labels — the boxed warning about thyroid C-cell tumors seen in animal studies, the contraindications around medullary thyroid carcinoma and Multiple Endocrine Neoplasia syndrome type 2, the cautions on pancreatitis, gallbladder disease, kidney problems and anesthesia — are properties of the medication, not of a dose level. Screening is what addresses those, at any dose.

Lower-than-standard dosing has not been studied the way the approved schedule has. The published trials tested the titration schedules on the FDA-approved products' labels, so their results describe those regimens — not a lower dose, and not a compounded preparation.

What makes any GLP-1 prescription reasonably safe?

• A licensed clinician reviews your history, your other medications and what is being treated — and can decide not to prescribe.
• The medication comes from a pharmacy you can identify and verify, not an unnamed supplier.
• You know what you are being prescribed: the molecule, the form, the dose, and whether it is compounded.
• There is a way to reach someone between refills when something changes.
• Dose changes are clinical decisions, made from check-ins, not self-service.

If a service cannot answer those, the dose is not the problem.

What should I ask before starting a microdose program?

1. Who will be prescribing, what their license is, and in which state — and can I verify it?
2. Is the medication compounded, and which pharmacy prepares it?
3. What exactly is in the preparation, and is anything added to it?
4. What is the beyond-use date, and how should I store it?
5. What dose am I starting on, who decides if it changes, and how?
6. What should make me contact you, and how fast can I reach someone?
7. What happens if this is not appropriate for me — do you say so?

What about compounded medication specifically?

A microdose program generally uses a compounded preparation, because the brand-name products come in fixed pen doses. That is a real difference worth understanding rather than glossing. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Compounding pharmacies are licensed and are subject to state and federal requirements, but that oversight is different in kind from the approval process a brand-name product goes through. You are entitled to know which pharmacy is involved and to ask what is in the preparation.

What is the clearest warning sign?

A service that approves everyone. Screening that never declines anyone is not screening; it is paperwork in front of a sale. A clinician who explains why treatment is not appropriate for you, and what the alternative is, is doing the job properly even though it is the answer nobody wants.

This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.